Clinical Trials Directory

Trials / Completed

CompletedNCT06175117

Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ)

A Multicenter, Randomized, Double-blind, Parallel Controlled Clinical Study on the Efficacy and Safety of Compound E Jiao Jiang(cEJJ)in the Treatment of Postpartum Anemia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
360 (actual)
Sponsor
DongE E Jiao Coporation Limited · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial\] is to compare the effect of compound E Jiao Jiang(cEJJ)combined with iron decoction on postpartum anemia.The main questions it aims to answer are: To evaluate the effectiveness of compound E Jiao Jiang(cEJJ) in the treatment of postpartum anemia. To evaluate the safety of compound E Jiao Jiang(cEJJ) in the treatment of postpartum anemia. To explore the effect of compound ejiao decoction on improving anxiety, depression, sleep and fatigue in postpartum anemia patients. Participants will be randomly assigned (like flipping a coin) to either the trial group or the control group (with a 50% chance of being assigned to either group), where the trial group will receive the compound E Jiao Jiang(cEJJ) + ferrous succinate tablet, and the control group will receive the compound E Jiao Jiang(cEJJ)placebo + ferrous succinate tablet. The compound E Jiao Jiang(cEJJ)placebo is the same/similar to the compound E Jiao Jiang(cEJJ) in terms of appearance, smell and taste, but has no therapeutic effect.And participants need to return to the research center on time for relevant examinations according to the protocol requirements.

Conditions

Interventions

TypeNameDescription
DRUGcompound E Jiao Jiang(cEJJ)compound E Jiao Jiang(cEJJ):20ml (1 bottle) at a time, 3 times a day, should be taken orally before morning, lunch and dinner.
DRUGcompound E Jiao Jiang(cEJJ) placebocompound E Jiao Jiang(cEJJ) placebo:20ml (1 bottle) at a time, 3 times a day, should be taken orally before morning, lunch and dinner.

Timeline

Start date
2023-01-07
Primary completion
2025-09-08
Completion
2025-09-08
First posted
2023-12-18
Last updated
2025-12-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06175117. Inclusion in this directory is not an endorsement.